Aug 01, 2024 / 07:30AM GMTOperator Good morning, and welcome to Fagron's H1 2024 results conference call, hosted by Rafael Padilla, CEO; and Karin de Jong, CFO.
Gereglementeerde informatie Nazareth (België)/Rotterdam (Nederland), 23 augustus 2024 – 18u CET Voortgang aandeleninkoopprogramma Fagron In de periode...
Regulated informationNazareth /Rotterdam , 13 May 2024 – 7PM CET Fagron shareholders approve all voting items at AGM and EGM Fagron, the leading global player in pharmaceutical compounding, held...
/PRNewswire/ -- The gene panel market size is expected to grow by USD 3.23 million from 2022 to 2027. In addition, the momentum of the market will be...
/PRNewswire/ -- The compounding pharmacy market size is estimated to grow by USD 1,682.04 million from 2022 to 2027. The market is estimated to accelerate at a...
26 May 2021 Alychlo NV announces today its intention to sell approximately 3.6 million existing ordinary shares in Fagron NV to institutional investors by means of a private placement via an...
In its newly compiled report, Future Market Insights (FMI) states that the global niacin and niacinamide market will showcase a steady rise over the forecast